SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-009293
Filing Date
2017-08-14
Accepted
2017-08-14 17:12:05
Documents
63
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 650484
2 ex31-1.htm EX-31.1 18250
3 ex31-2.htm EX-31.2 16931
4 ex32-1.htm EX-32.1 7064
5 ex32-2.htm EX-32.2 6929
6 image_002.jpg GRAPHIC 26644
  Complete submission text file 0001493152-17-009293.txt   3427165

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE heb-20170630.xml EX-101.INS 574834
8 XBRL SCHEMA FILE heb-20170630.xsd EX-101.SCH 47629
9 XBRL CALCULATION FILE heb-20170630_cal.xml EX-101.CAL 47688
10 XBRL DEFINITION FILE heb-20170630_def.xml EX-101.DEF 150027
11 XBRL LABEL FILE heb-20170630_lab.xml EX-101.LAB 323153
12 XBRL PRESENTATION FILE heb-20170630_pre.xml EX-101.PRE 221437
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27072 | Film No.: 171031499
SIC: 2836 Biological Products, (No Diagnostic Substances)